< sup > 89 < /sup > Zr-immuno-PET using the anti-LAG-3 tracer [ < sup > 89 < /sup > Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC

CONCLUSIONS: [89Zr]Zr-BI-754111 PET imaging shows favorable technical and biological characteristics for developing a potential predictive imaging biomarker for LAG-3-directed therapies.TRIAL REGISTRATION: ClinicalTrials.gov , NCT03780725. Registered 19 December 2018.PMID:36859619 | DOI:10.1007/s00259-023-06164-w
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research